CAS 1784253-05-9

CZC-54252 hydrochloride

CAS : 1784253-05-9

CZC-54252 hydrochloride

Formule : C₂₂H₂₆Cl₂N₆O₄S

Degré de pureté : ≥98%

Masse moléculaire : 541.45

Ref: 54-BUP10681

CZC 54252 hydrochloride

CAS : 1784253-05-9

Formule : C₂₂H₂₆Cl₂N₆O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 541.4506

Ref: IN-DA01LQQX

CZC-54252 hydrochloride

CAS : 1784253-05-9

CZC-54252 hydrochloride: selective LRRK2 inhibitor; IC50 = 1.85/1.28 nM (wild-type/G2019S); neuroprotective; EC50 = 1 nM for G2019S injury.

Formule : C₂₂H₂₆Cl₂N₆O₄S

Degré de pureté : 98.21%

Couleur et forme : Solid

Masse moléculaire : 541.45

Ref: TM-T39202

CZC 54252 hydrochloride

CAS : 1784253-05-9

CZC 54252 hydrochloride is a cancer drug that inhibits the growth of cancer cells by inhibiting the production of DNA and RNA. It binds to topoisomerase II, which is an enzyme that maintains the integrity of DNA. CZC 54252 hydrochloride also inhibits protein synthesis, leading to cell death. This drug has been shown to be effective against a variety of cancers, such as colon and lung cancer.

Formule : C₂₂H₂₆Cl₂N₆O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 541.4 g/mol

Ref: 3D-JWC25305